Genetics of Premature Ovarian Insufficiency: From Molecular Architecture to Precision Medicine
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27198662 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Vanessa Sousa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cytogenetics Laboratory, School of Medicine and Biomedical Sciences, University of Porto, Rua Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, Precision Medicine. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Premature ovarian insufficiency (POI) affects 1–3.7% of women and causes infertility and long-term morbidity. Next-generation sequencing has identified more than 130 POI-associated genes. The diagnostic yield of genetic testing depends on cohort size and the quality and scope of the genetic analysis, reaching 29.3% in our largest international cohort reported to date. Major biological pathways involve meiosis/DNA repair, follicular growth, and mitochondrial/metabolic functions. Meiosis/DNA-repair defects can impair fetal establishment of the ovarian reserve and, depending on the gene, variant, and allelic state, may be associated with chromosomal instability or cancer predisposition. This could enable early identification of selected at-risk patients, oncogenetic assessment, and cancer-prevention strategies. In contrast, alterations affecting follicular growth, metabolism, or mitochondrial function may be associated with persistence of a residual follicular pool, revealing a limited window of opportunity for timely fertility preservation in selected patients and at-risk relatives. Genetic diagnosis provides actionable information for etiological classification, and can reveal a syndromic condition, guide family screening, and, in selected genotypes, inform comorbidity assessment and early fertility preservation. It may also guide future mechanism-based therapies. By translating molecular findings into individualized reproductive and long-term care, POI provides a paradigmatic model of precision medicine in female infertility and reproductive endocrinology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cytogenetics Laboratory, School of Medicine and Biomedical Sciences, University of Porto, Rua Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
- Unit for Multidisciplinary Research in Biomedicine, School of Medicine and Biomedical Sciences, University of Porto, Rua Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
- Stabilité Génétique Cellules Souches et Radiations, LDG/iRCM/IBFJ, Inserm, CEA, Université Paris Cité, F-92260 Fontenay-Aux-Roses, France.
- Stabilité Génétique Cellules Souches et Radiations, LDG/iRCM/IBFJ, Inserm, CEA, Université Paris-Saclay, F-92260 Fontenay-Aux-Roses, France.
- Unité de Génétique Moléculaire des Maladies Métaboliques et de la Reproduction, Hôpital Bicêtre AP-HP, Hôpitaux Universitaires Paris-Saclay, Faculté de Médecine, Université Paris-Saclay, 94275 Le Kremlin-Bicetre, France.
ORCID-Profile: Vanessa Sousa, Micheline Misrahi
Zitieren
APA
Sousa, V., Livera, G., & Misrahi, M. (2026). Genetics of Premature Ovarian Insufficiency: From Molecular Architecture to Precision Medicine. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198662
Vancouver
Sousa V, Livera G, Misrahi M. Genetics of Premature Ovarian Insufficiency: From Molecular Architecture to Precision Medicine. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198662
BibTeX
@article{Sousa2026,
author = {Sousa, Vanessa and Livera, Gabriel and Misrahi, Micheline},
title = {Genetics of Premature Ovarian Insufficiency: From Molecular Architecture to Precision Medicine},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27198662}
}
EUVIMED